← All trials
NCT05309668
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 21, 2022
- Primary completion
- Oct 19, 2023
- Completion date
- Jul 9, 2027
- First posted
- Apr 4, 2022
- Last posted
- Dec 1, 2022
- Enrollment
- 38
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- AstraZenecaLead sponsor
- AstraZenecaStudy director
- MerckCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.